Beauty Launchpad Announces 30 Over 30 Winners for 2024
Beauty Launchpad
MAY 6, 2024
Congratulations to this year's winners of Beauty Launchpad's 30 Over 30 contest, sponsored by Denman Brush, spotlighting 30 stylists over 30 years of age.
Beauty Launchpad
MAY 6, 2024
Congratulations to this year's winners of Beauty Launchpad's 30 Over 30 contest, sponsored by Denman Brush, spotlighting 30 stylists over 30 years of age.
Beautiful With Brains - Ingredients
MAY 6, 2024
Curious about bamboo skincare? Me too. When you say bamboo, I think of cute pandas lazily munching on their leaves up in the Chinese mountains. So cute! But bamboo isn’t just food for pandas. If you’re into Korean skincare, you’ve probably noticed bamboo has found its way into your skincare stash, too. Bamboo water has […] The post Not Just Panda Food: Why Bamboo Is The Next Big Thing In Korean Skincare appeared first on Beautiful With Brains.
The Dermatology Digest
MAY 6, 2024
It’s Melanoma Monday, and TDD Editorial Advisory Board Member Vishal Patel, MD, an Associate Professor of Dermatology at the GW School of Medicine & Health Sciences and the Director of the Cutaneous Oncology Program at the GW Cancer Center in Washington, DC, highlights recent advances in diagnosing and treating melanoma, including the approval of the DermaSensor device for detection in the primary care setting and new evidence that neoadjuvant immunotherapy before surgery improves outc
AAFE - American Academy of Facial Esthetics
MAY 6, 2024
Register today for Atlanta, GA - May 29-30 - Botulinum Toxin and Dermal Fillers Training Course
Dermatology Times
MAY 6, 2024
Marc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide fundings and resources for melanoma research.
The Studio Academy of Beauty
MAY 6, 2024
We've all heard people say condescending and incorrect things about beauty school graduates, so we wanted to talk to you about some misconceptions in the field. In this blog, we're going to go over five beauty school myths, then we'll tell you why they're wrong. Let's get started. The post Top 5 Beauty School Myths Debunked first appeared on The Studio Academy of Beauty.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
The Studio Academy of Beauty
MAY 6, 2024
Beauty school isn’t for the weak, and beauty school students can make a huge difference in the world, just like other working professionals do. Despite common misconceptions about the field, the beauty industry is incredibly important because cosmetologists, hair stylists, nail technicians, and other professionals make people feel good about themselves.
Dermatology Times
MAY 6, 2024
Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month and Melanoma Monday.
AAFE - American Academy of Facial Esthetics
MAY 6, 2024
Register today for Atlanta, GA - Jun.
Dermatology Times
MAY 6, 2024
Researchers found that the diameter of cutaneous melanoma demonstrated a weak positive correlation with tumor thickness.
Beauty Launchpad
MAY 6, 2024
Akela Douglass (@akelashair) is the owner of Got Roots Color Bar in Sacramento, CA and a national educator.
Dermatology Times
MAY 6, 2024
Dozens of investigators shared findings to advance care in patients with melanoma during Mohs micrographic surgery.
The Dermatology Digest
MAY 6, 2024
Dr. Reddy’s Laboratories Ltd. is launching of Doxycycline Capsules, 40mg in the U.S. market, a therapeutic generic equivalent of Oracea (Galderma) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA). Oracea is indicated for the treatment of only inflammatory lesions of rosacea in adult patients. Dr. Reddyās Doxycycline Capsules, 40 mg, are supplied in bottle counts of 30.
Dermatology Times
MAY 6, 2024
Elizabeth Kiracofe, MD, provides a look at an upcoming DermView program that will explore systemic treatments for atopic dermatitis in the context of reproductive health, for patients during pregnancy, pre-pregnancy, postpartum, and breastfeeding.
The Dermatology Digest
MAY 6, 2024
Treatment with Inmagene Biopharmaceuticalsā anti-OX40 monoclonal antibodyled to ārapid, marked, and durableā improvements of skin signs in in a Phase 2a trial of patients with atopic dermatitis (AD) IMG-007 is a non-depleting anti-OX40 mAb, bioengineered to have a silenced antibody-dependent cellular cytotoxicity (ADCC) function and a prolonged half-life.
Dermatology Times
MAY 6, 2024
The Harris brothers serve 2 predominantly elderly populations and appreciate the opportunity to provide solutions for the growing complexity of skin cancer issues as patients live longer.
Let's personalize your content